AUSTIN, Texas, July 07, 2025--(BUSINESS WIRE)--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) ("IPA" or the "Company"), an AI-powered biotherapeutics company, today announced the appointment of Jon ...
BOSTON, Oct. 7, 2026 /PRNewswire/ -- Bambusa Therapeutics, Inc. ("Bambusa Therapeutics" or "Bambusa"), a clinical-stage ...
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), an AI-powered biotherapeutics company, today announced the appointment of Jon Lieber to its Board of Directors, effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results